Article info
PDFOriginal research
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus
- Correspondence to Dr Michaela Onstad, Gynecologic Oncology & Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; maonstad{at}mdanderson.org
Citation
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus
Publication history
- Received August 1, 2019
- Revision received December 12, 2019
- Accepted December 16, 2019
- First published January 23, 2020.
Article Versions
- You are currently viewing a Previous version of this article (9 April 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.